Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.39 |
| ▸ | MMP13 | P45452 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | REN | P00797 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24297646 | 0.82 | AAK1 (0.37) | AAK1MMP13CA14HDAC1HDAC2 | |
| SCHEMBL68034 | 0.81 | MMP13 (0.38) | AAK1MMP13HDAC1HDAC2HDAC6 | |
| SCHEMBL68033 | 0.81 | MMP13 (0.38) | AAK1MMP13HDAC1HDAC2HDAC6 | |
| SCHEMBL21447929 | 0.79 | MMP13 (0.37) | AAK1MMP13HDAC1HDAC2HDAC6 | |
| SCHEMBL17618251 | 0.76 | AAK1 (0.36) | AAK1MMP13CA14HDAC1HDAC2 | |
| SCHEMBL21258087 | 0.76 | AAK1 (0.36) | AAK1MMP13CA14HDAC1HDAC2 | |
| SCHEMBL4426560 | 0.76 | REN (0.50) | AAK1MMP13REN | |
| SCHEMBL20440150 | 0.75 | CTSS (0.45) | AAK1MMP13REN | |
| SCHEMBL22035316 | 0.74 | ADORA1 (0.46) | AAK1MMP13REN | |
| SCHEMBL6321168 | 0.74 | CTSS (0.46) | AAK1MMP13HDAC6REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007070201-A1 | ASPARTIC PROTEASE INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-06-21 | — | — | WO | disclosed |